Accession Number:

ADA622204

Title:

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections in the Department of Defense (DOD): Annual Summary Report 2014

Descriptive Note:

Annual rept. 1 Jan-31 Dec 2014

Corporate Author:

NAVY AND MARINE CORPS PUBLIC HEALTH CENTER PORTSMOUTH VA EPIDATA CENTER DEPT

Personal Author(s):

Report Date:

2015-10-01

Pagination or Media Count:

13.0

Abstract:

Methicillin-resistant Staphylococcus aureus MRSA infections are a national concern for public health and hospital officials due to the opportunistic nature of the bacteria and the emergence of resistance to several antibiotics. In 2014, the MRSA incidence rates were 60.0 and 70.5 per 100,000 person years in the Department of Defense DOD and the Department of the Navy DON beneficiary populations, respectively this is a 56.8 decrease for the DOD and a 60.4 decrease for the DON since 2005. The majority of MRSA infections within the DOD and DON in 2014 were outpatient, community-associated CA, and skin and soft tissue infections SSTIs. Among DOD and DON beneficiaries, MRSA isolates were most susceptible to vancomycin, linezolid, and rifampin, and least susceptible to amoxicillinclavulanate, ceftriaxone, and cefazolin. The proportion of MRSA cases with inducible clindamycin resistance is increasing, with a 30.1 increase in the DOD and a 51.2 increase in the DON from 2005 to 2014. Military prescription practices in 2014 were consistent with treatments recommended by the Infectious Diseases Society of America IDSA.

Subject Categories:

  • Anatomy and Physiology
  • Medicine and Medical Research
  • Microbiology

Distribution Statement:

APPROVED FOR PUBLIC RELEASE